Table 4.

Distribution of cases and controls by 4-ABP-Hb adducts (detectable/not detectable, n= 339)

Detectable 4-ABP-Hb adducts, n (%)OR (95% CI)
Controls (n = 190)74 (39)
Lung cancer (n = 29)12 (41)1.05 (0.45-2.45)
Bladder cancer (n = 30)13 (43)1.28 (0.55-2.97)
Leukemias (n = 46)21 (46)1.33 (0.66-2.67)
Oral cancer (n = 15)8 (53)2.13 (0.70-6.53)
Pharyngeal-laryngeal (n = 9)5 (56)1.79 (0.44-7.27)
COPD or emphysema deaths (n = 20)6 (30)0.62 (0.22-1.75)
  • NOTE: Data were adjusted for country, gender, age at recruitment, smoking status, cotinine, and fruit and vegetable intake.

    Abbreviations: OR, odds ratio; COPD, chronic obstructive pulmonary disease.